Fig. 5
In vitro therapy assessing the effect of monotherapy (rapamycin or 177Lu-labelled LF1) and combination therapy (rapamycin and 177Lu-laballed LF1) on PC3 cells
Fig. 5 | EJNMMI Radiopharmacy and Chemistry
In vitro therapy assessing the effect of monotherapy (rapamycin or 177Lu-labelled LF1) and combination therapy (rapamycin and 177Lu-laballed LF1) on PC3 cells